Hi, Joe, I just checked my direct reply to you on this

New Post Public Reply Private Reply Replies (0) Message Board
Buildit
389
Hi, Joe,

I just checked my direct reply to you on this board, dated 11/30/19 and sent at your request, after the CMP announcement. In that reply, I gave my full name as well as my YMB alias.

I did include many personal thoughts in what I thought was a well-intentioned and well thought-out letter. As I said, I received no reply.

Please check the shareholder list if you would like. You will see that I own what is for me (and for most people) a substantial amount of shares (along with my wife, same last name). I have never sold a share in 10 years as a shareholder.

Please also feel free to go to YMB and read my posts... hundreds of them over the past 15 months... mostly trying to defend you and GNBT from the rampant idiocy there, spread the truth to new posters, and discredit those spreading false information.

You could also go back and read my posts under this alias. I think you will see that, mixed with occasional frustration, I have also tried to be constructive on this site.

As I said in my direct message, I have spent a lot of time trying to keep up with all of the information regarding Generex, its many deals and potential deals, the dividends, etc. For some of us, this has been almost like having a second job (and we, like you, work hard at our real jobs as well). We are not professional investors, but we're doing our best.

When GNBT hits the Naz, we will happily read the analyses by the professionals instead of trying to cobble this all together in our own brains. In the meantime, you're stuck with us and our shortfalls, as well as our posts on the boards as we try to navigate this together.

In a nutshell, please know we are still behind you and the company and treat us with some level of patience and respect.

Thanks, and have a relaxing weekend.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 1

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 1

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 8

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 1

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading

Top 5 Most Recently Viewed Articles

92,000 SF Leased in Frederick: Matan Clinches Deals

Updated Category News Views 30

Trudging through the week, I caught wind of a deal shaking up the industrial real estate sector in Frederick, Maryland. Matan Companies, a big name in the industrial development game, has bagged two hefty leases that throw more than 92,000 square feet on their already impressive portfolio board. If you've ever doubted Frederick's allure, these deals slap that skepticism...

Continue Reading
Kestrel Group Reports Positive Q2 2025 Financial Performance

Updated Category News Views 195

Kestrel Group Delivers Second Quarter Financial Results Kestrel Group Ltd (NASDAQ: KG) has recently unveiled its financial performance for the second quarter that wrapped up mid-year. The company's effective strategies are reflected in its ongoing financial stability and growth trajectory. Key Financial Highlights for the Quarter In the latest financial disclosure,...

Continue Reading
Oxbridge Re Holdings Discusses Innovation in RWA Tokenization

Updated Category News Views 175

Exciting Developments at ETHDenver 2025 Oxbridge Re Holdings Limited (NASDAQ: OXBR), a pioneering company in the tokenization of Real-World Assets (RWAs), is gearing up for an exciting event at ETHDenver 2025. With its subsidiary, SurancePlus, the company operates at the forefront of merging blockchain technology with reinsurance, enhancing investment opportunities for...

Continue Reading
Ameren Corporation's Strategic Move with New Senior Notes

Updated Category News Views 287

Ameren Corporation's Senior Notes Pricing Announcement Ameren Corporation (NYSE: AEE) has made headlines with its recent announcement of the pricing for a public offering of senior notes. This strategic financial maneuver involves an impressive $750 million of 5.375% senior notes, due in 2035. The offering, which is priced at 99.822% of the principal amount, is poised to...

Continue Reading
Inari Medical Revolutionizes Arteriovenous Treatment with InThrill

Updated Category News Views 123

Inari Medical Unveils Revolutionary InThrill Thrombectomy System Inari Medical, a valued subsidiary of Stryker (NYSE: SYK), has introduced the InThrill Thrombectomy System, a groundbreaking solution designed specifically for arteriovenous access and small vessel thrombus procedures. This innovative system stands as the first and only dedicated tool tailored for fast and...

Continue Reading